Glycomimetics Inc (GLYC)

$2.26 0.17 (8.13%)
16:00 EDT GLYC Stock Quote Delayed 30 Minutes

GlycoMimetics Stock Has Substantial Upside

GlycoMimetics reported no surprises and even beat consensus estimates on earnings. The company has many drugs in clinical trials for treating cancer, AML and MM.
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 116.48M
PE Ratio -1.92
EPS -1.18
Volume (Avg. Vol.) 335,639
Day's Range 2.10 - 2.26
52-Week Range 1.78 - 4.40
Dividend & Yield N/A (N/A)